ICICI Bank Board Approves Q2 2025 Financial Results

Ticker: IBN · Form: 6-K · Filed: Oct 24, 2025 · CIK: 1103838

Sentiment: neutral

Topics: financial-results, board-meeting, disclosure

Related Tickers: IBN

TL;DR

ICICI Bank board OK'd Q2 results on Oct 18. Check the 6-K for details.

AI Summary

ICICI Bank Limited announced on October 18, 2025, that its Board of Directors approved unaudited financial results for the quarter and six months ended September 30, 2025. The filing also includes limited review reports and a news release.

Why It Matters

This filing provides investors with the latest unaudited financial performance of ICICI Bank, crucial for assessing the bank's current health and future prospects.

Risk Assessment

Risk Level: low — This is a routine financial results disclosure, not indicating any immediate operational or financial distress.

Key Players & Entities

FAQ

What specific financial figures were approved for the quarter and six months ended September 30, 2025?

The filing states that unaudited financial results for the quarter and six months ended September 30, 2025, were approved, but the specific figures are detailed in Annexure I, which is not fully provided in this excerpt.

When was the Board of Directors meeting held to approve these results?

The Board of Directors meeting was held on October 18, 2025.

What is the filing type and its purpose?

This is a Form 6-K, a Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934, used to provide information to the SEC for the month of October 2025.

Where is ICICI Bank Limited's principal executive office located?

ICICI Bank Limited's principal executive office is located at ICICI Bank Towers, Bandra-Kurla Complex, Mumbai, India, 400 051.

Does ICICI Bank file annual reports under Form 20-F or Form 40-F?

ICICI Bank indicates it files annual reports under Form 20-F.

Filing Stats: 3,898 words · 16 min read · ~13 pages · Grade level 5 · Accepted 2025-10-24 06:03:31

Filing Documents

business

business 19,524.33 15,872.36 17,341.60 35,396.69 31,988.27 73,806.18 i) Other operating expenses 8,510.76 7,658.58 7,504.12 16,169.34 14,762.76 30,363.86 6. TOTAL EXPENDITURE EXCLUDING PROVISIONS AND CONTINGENCIES (4)+(5) 56,172.70 53,259.22 53,064.21 109,431.92 102,256.99 216,827.63 7. OPERATING PROFIT BEFORE PROVISIONS AND CONTINGENCIES (3)–(6) 19,973.89 21,316.81 19,878.34 41,290.70 37,955.62 77,759.31 8. Provisions (other than tax) and contingencies 909.31 1,822.33 1,381.88 2,731.64 2,697.77 4,905.76 9. PROFIT FROM ORDINARY ACTIVITIES BEFORE EXCEPTIONAL ITEMS AND TAX (7)–(8) 19,064.58 19,494.48 18,496.46 38,559.06 35,257.85 72,853.55 10. Exceptional items .. .. .. .. .. .. 11. Add: Share of profit in associates 61.75 62.53 45.19 124.28 102.06 50.66 12. PROFIT FROM ORDINARY ACTIVITIES BEFORE TAX AND MINORITY INTEREST (9)–(10)+(11) 19,126.33 19,557.01 18,541.65 38,683.34 35,359.91 73,004.21 13. Tax expense (j)+(k) 4,808.18 5,100.68 4,635.66 9,908.86 8,991.11 18,434.83 j) Current tax 4,580.50 4,901.00 4,214.41 9,481.50 8,309.15 17,497.17 k) Deferred tax 227.68 199.68 421.25 427.36 681.96 937.66 14. Less: Share of profit/(loss) of minority shareholders 961.09 898.73 958.22 1,859.82 1,725.19 3,540.18 15. NET PROFIT FROM ORDINARY ACTIVITIES AFTER TAX (12)–(13)–(14) 13,357.06 13,557.60 12,947.77 26,914.66 24,643.61 51,029.20 16. Extraordinary items (net of tax expense) .. .. .. .. .. .. 17. NET PROFIT FOR THE PERIOD (15)-(16) 13,357.06 13,557.60 12,947.77 26,914.66 24,643.61 51,029.20 18. Paid-up equity share capital (face value 2/- each) 1,428.95 1,427.32 1,409.45 1,428.95 1,409.45 1,424.60 19. Reserves excluding revaluation reserves 306,631.95 20. Earnings per share (EPS) Basic EPS before and after extraordinary items, net of tax expense (not annualised) (in ) 18.71 19.02 18.39

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing